Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays (original) (raw)
The Value of Serum Immunoglobulin Free Light Chain Assessment in Patients with Monoclonal Gammopathies and Acute Renal Failure
Mustafa Cirit
Turkish Journal of Hematology, 2012
View PDFchevron_right
Abnormal serum free light chain ratio does not always indicate monoclonal gammopathy
Bogdan Ochrem
Polskie Archiwum Medycyny Wewnętrznej, 2015
View PDFchevron_right
Comparison of the free and total light chain assays in serum and urine samples with immunofixation electrophoresis for detecting monoclonal proteins in patients with monoclonal gammopathy
Marta Morawska
Current Issues in Pharmacy and Medical Sciences, 2014
View PDFchevron_right
Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: Correlation with 24-hr urinary light-chain excretion
Pierre Aucouturier
American Journal of Hematology, 2004
View PDFchevron_right
Comparison of Freelite and N-Latex serum free light chain assays
Andrea Piccin
Biochemia medica, 2021
View PDFchevron_right
A new free light chain immunoassay shows advantages in the classification and in the follow-up of patients with paraproteinemia compared to a nephelometric assay
OSMAN EVLİYAOĞLU
Hematology and Medical Oncology, 2019
View PDFchevron_right
Laboratory testing in monoclonal gammopathy of renal significance (MGRS)
Nelson Leung
Clinical Chemistry and Laboratory Medicine (CCLM), 2016
View PDFchevron_right
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications for Monitoring Monoclonal Gammopathies
Angela Dispenzieri
Clinical Chemistry, 2011
View PDFchevron_right
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
Dirk Larson
Blood, 2005
View PDFchevron_right
The association of serum-free light-chain levels with markers of renal function
Bilge Karatoy Erdem
Renal Failure, 2015
View PDFchevron_right
Serum free light chains in clinical laboratory diagnostics
Yun Wang
View PDFchevron_right
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
Efstathios Kastritis
Nature Reviews Nephrology
View PDFchevron_right
Diagnostic Performance of Quantitative and Free Light Chain Assays in Clinical Practice
Angela Dispenzieri
Clinical Chemistry, 2005
View PDFchevron_right
A brief review on free light chain assays: from conventional to current
SUBASHINI A/P CHELLAPPAH THAMBIAH / MEDIC
2017
View PDFchevron_right
Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice
Rhona Souers
Archives of Pathology & Laboratory Medicine, 2017
View PDFchevron_right
Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine
Sandra Klingberg
Clinical Chemistry and Laboratory Medicine, 2014
View PDFchevron_right
Pathophysiology and management of monoclonal gammopathy of renal significance
Maria Soares
Blood Advances
View PDFchevron_right
The spectrum of monoclonal gammopathies affecting the kidney
Nelson Leung
Leukemia & Lymphoma, 2012
View PDFchevron_right
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure
Tim Plant
BMC Nephrology, 2008
View PDFchevron_right
Comparision of the diagnostic sensitivity of biochemical tests in the screening of monoclonal gammopathy
Innovative Publication
International Journal of Clinical Biochemistry and Research, 2023
View PDFchevron_right
Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy
OSMAN EVLİYAOĞLU
Clinical Biochemistry, 2019
View PDFchevron_right
A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine
Nelson Leung
Clinical journal of the American Society of Nephrology : CJASN, 2016
View PDFchevron_right
Serum free light chain quantitative assays: Dilemma of a biomarker
Giovanni Cigliana
Journal of clinical laboratory analysis, 2017
View PDFchevron_right
A multicentre study comparing two methods for serum free light chain analysis
Anthony Rowbottom
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2013
View PDFchevron_right
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant
Nelson Leung
Blood, 2012
View PDFchevron_right
Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease
Giulia Ligabue
International Journal of Nephrology, 2021
View PDFchevron_right
Monoclonal gammopathy of renal significance: Early diagnosis is key
Domingo Hernández
Nefrología, 2021
View PDFchevron_right
When an Analytical Interference Is a Useful Diagnostic Tool: Finding Monoclonal Gammopathies in Routine Analysis
Carmen Torrelo
Journal of Clinical Laboratory Analysis, 2014
View PDFchevron_right
Reducing diagnostic errors — Recognizing monoclonal gammopathy of renal significance (MGRS)
Konstantinos Liapis
Hospital chronicles, 2017
View PDFchevron_right
SP161PREVALENCE of Kidney Disease in Monoclonal Gammopathy of Undetermined Significance
Wenceslao Morales
Nephrology Dialysis Transplantation, 2019
View PDFchevron_right
Benign monoclonal gammopathy presenting with severe renal failure
V. Redoglia
Scandinavian Journal of Haematology, 2009
View PDFchevron_right
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study
Dirk Larson
The Lancet, 2010
View PDFchevron_right